Description

Rituximab Injection is a monoclonal antibody used to treat various conditions, including non-Hodgkin lymphoma and rheumatoid arthritis. It targets CD20 proteins on B-cells, leading to cell destruction, reducing disease progression, and improving outcomes in patients with these conditions.